Brief: Ultimovacs Gets FDA Orphan Drug Designation For UV1 Cancer Vaccine

Zelluna ASA

09/10/2023 06:05

Oct 9 (Reuters) - Ultimovacs ASA  ULTI.OL :
    * ULTIMOVACS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR UV1
CANCER
VACCINE FOR TREATMENT OF MESOTHELIOMA
    * RESULTS FROM NIPU STUDY WILL BE PRESENTED AT ESMO CONGRESS
BEING
HELD OCTOBER 20-24, 2023

Source text for Eikon:  ID:nGNEbyqpQ1 
Further company coverage:  ULTI.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))